H.C. Wainwright Reiterates Buy Rating on Gevo, Inc. (GEVO)
Get Alerts GEVO Hot Sheet
Rating Summary:
10 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 28
Join SI Premium – FREE
H.C. Wainwright analyst Amit Dayal reiterated a Buy rating and $14.00 price target on Gevo, Inc. (NASDAQ: GEVO).
The analyst commented: "On October 8, Gevo sold 10,000 CO₂-removal credits through ClimeFi to a corporate buyer, demonstrating commercial monetization of carbon captured and permanently stored at Gevo North Dakota (GND). Earlier, Gevo had announced contracted sales of $70M worth of 2026 Section 45Z tax credits; the company has already received more than $30M in cash through September 30, 2026, and expects the remaining cash over the following six months. Management expects GND de-bottlenecking, already underway, to generate an additional $7-10M worth of credits in 2027, with targeted annual production capacity of 75M gallons by year-end 2026. A significant operational milestone was announced on September 14, 2026, with Gevo North Dakota’s CO₂ degassing system entered commissioning several weeks ahead of plan, following the August commissioning of a steam turbine; the remaining liquefaction and fermentation upgrades are expected to be operational by December 2026. Internationally, Gevo is commercializing its renewable isobutanol (Bio-IBA) technology in India, having granted Praj exclusive rights, with an initial emphasis on diesel blending and combining Gevo’s technology with Praj’s engineering and market-development capabilities. Praj is also establishing a demonstration plant for an Indian oil marketing company (OMC) using Gevo’s licensed technology. Reiterate Buy rating and $14 PT."
For an analyst ratings summary and ratings history on Gevo, Inc. click here. For more ratings news on Gevo, Inc. click here.
Shares of Gevo, Inc. closed at $1.35 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Investors need sustained Fed cuts to move cash off sidelines: BofA's Hartnett
- BofA Securities Downgrades Alignment Healthcare Inc (ALHC) to Neutral
- Elastic NV. (ESTC) PT Raised to $120 at Stifel on Improving Customer Commentary, Strong U.S. Federal Checks
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Maynard Um, H.C. Wainwright, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share